BriaCell Therapeutics Corp. - 10-K Filing

BriaCell Therapeutics Corp. reports fiscal year ending July 31, 2025, with extensive disclosures regarding warrant liabilities and share purchase agreements.

3 articles from 1 source · updated October 29, 2026, 10:01 UTC

Coverage

• Viking Therapeutics, Inc. - 10-Q Filing SEC EDGAR · October 29, 2026, 10:00 UTC
• Lycia Therapeutics, Inc. - 4 Filing SEC EDGAR · October 28, 2026, 21:28 UTC
• BriaCell Therapeutics Corp. - 10-K Filing SEC EDGAR · October 28, 2026, 20:43 UTC